chemistry

Chemoproteomic tools are yielding early drug candidates for previously undruggable proteins.

The new complex is inexpensive to produce, and its unique architecture makes chemical reactions integral to drug discovery more stable and efficient.

Fully synthetic approaches expand the repertoire of possible antimicrobials to overcome existing antibiotic resistance mechanisms.

Researchers designed a nanoparticle that inactivated a wide range of COVID-19 strains, potentially offering a broad-spectrum therapeutic approach.

Microbiome researcher Sarah Lebeer studies how beneficial bacteria can help treat inflammatory skin conditions such as acne and atopic dermatitis.

Mireille Kamariza develops new chemistry-driven diagnostics for tuberculosis that can reduce the time to treatment from weeks to minutes.

Emily Mevers investigates the compounds produced by millipedes that may inspire the medicines of the future.

Improved chemistry may make RNA editing therapies more feasible in humans.

LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.

Rice University chemists detail a greener way to make pharmaceutical intermediates